Published in J Immunol on June 01, 1969
Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010) 5.21
The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J Exp Med (1978) 4.01
Effects of local immunization with Streptococcus mutans on induction of salivary immunoglobulin A antibody and experimental dental caries in rats. Infect Immun (1974) 3.31
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun (1994) 2.56
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun (1997) 2.49
The presence of IgA on the surface of rat thoractic duct lymphocytes which contain internal IgA. J Exp Med (1975) 2.08
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Infect Immun (1978) 1.84
Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol (1998) 1.80
The demonstration and function of antibodies in the gastrointestinal tract. Gut (1972) 1.53
Intestinal secretion of immunoglobulins in the preruminant calf. Immunology (1972) 1.48
Intestinal antibody secretion in the young pig in response to oral immunization with Escherichia coli. Immunology (1974) 1.47
The antibody response to bacterial gastroenteritis in serum and secretions. Clin Exp Immunol (1980) 1.43
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun (1995) 1.35
Comparison of an enzyme-linked immunosorbent assay for quantitation of rotavirus antibodies with complement fixation in an epidemiological survey. J Clin Microbiol (1978) 1.33
Antibody response in the parotid fluid and serum of Irus monkeys (Macaca fascicularis) after local immunization with Streptococcus mutans. Infect Immun (1975) 1.31
Immune-mediated emigration of neutrophils into the lumen of the small intestine. Infect Immun (1974) 1.27
Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun (1972) 1.21
Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol (1988) 1.20
Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun (1998) 1.20
Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants. Infect Immun (1983) 1.20
Serum and intestinal immune response to rotavirus enteritis in children. Infect Immun (1983) 1.15
Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun (1998) 1.10
Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ (1994) 1.08
Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1970) 1.08
Anti-reticulin antibody in jejunal juice in coeliac disease. Clin Exp Immunol (1975) 1.03
Bacterial agglutination studies with secretory IgA prepared from human gastrointestinal secretions and colostrum. Gut (1972) 1.02
Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun (1999) 1.01
Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J Virol (1987) 1.00
Localization of immunoglobulins in intestinal mucosa and the production of secretory antibodies in response to intraluminal administration of bacterial antigens in the preruminant calf. Clin Exp Immunol (1975) 0.99
IgA antibodies in the bile of rats. II. Evidence for immunological memory in secretory immunity. Immunology (1982) 0.99
Distribution of echovirus antibody in serum, nasopharynx, rectum, and spinal fluid after natural infection with echovirus type 6. Infect Immun (1970) 0.97
Selective absence of IgA. Autoimmune phenomena and autoimmune disease. Am J Pathol (1972) 0.97
Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun (1991) 0.95
Traveler's diarrhea associated with rotavirus infection: analysis of virus-specific immunoglobulin classes. Infect Immun (1981) 0.95
Neutralizing activity in the gastrointestinal contents of piglets vaccinated with a live or formaldehyde-inactivated porcine enterovirus. Can J Comp Med (1976) 0.94
Comparison fo agglutinin titers for Streptococcus mutans in tears, saliva, and serum. Infect Immun (1982) 0.93
Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol (1991) 0.93
Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect Immun (1980) 0.92
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands. Clin Diagn Lab Immunol (1997) 0.92
T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci U S A (1993) 0.89
Characterization of the local and systemic virus neutralizing activity in swine vaccinated with a porcine enterovirus. Can J Comp Med (1977) 0.87
Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys. Infect Immun (1973) 0.87
In vitro immunoglobulin synthesis by human intestinal lamina propria lymphocytes. Gut (1984) 0.86
Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs. PLoS One (2012) 0.86
Immunoglobulin A antibody levels in human tears, saliva, and serum. Infect Immun (1982) 0.85
Mucosal immune response to RDEC-1 infection: study of lamina propria antibody-producing cells and biliary antibody. Infect Immun (1992) 0.85
Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther (2010) 0.85
Prenatal immunization by the oral route: stimulation of Brucella antibody in fetal lambs. Infect Immun (1972) 0.84
The human intestinal IgA response; burning questions. Front Immunol (2012) 0.84
The intestinal B-cell response in celiac disease. Front Immunol (2012) 0.84
The protective effect of two porcine enterovirus vaccines in swine. Can J Comp Med (1977) 0.82
The gastrointestinal frontier: IgA and viruses. Front Immunol (2013) 0.82
Immunoglobulins and the gut. Gut (1972) 0.81
Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization. Vaccine (2010) 0.80
Bladder, bowel and bugs--bacteriuria in patients with intestinal urinary diversion. World J Urol (2004) 0.79
Systemic cellular hypersensitivity induced by an intestinally absorbed antigen. J Exp Med (1974) 0.79
Effect of bursectomy and depletion of immunoglobulin A on antibody production and resistance to respiratory challenge after local or systemic vaccination of chickens with Newcastle disease virus. Infect Immun (1977) 0.79
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview. World J Virol (2012) 0.78
Studies of the immunoglobulin-producing cells of the human intestine: the defunctioned bowel. Gut (1982) 0.78
Immunoglobulin synthesis and antibody content in the small intestine of the rabbit. Clin Exp Immunol (1975) 0.76
Antibody responses in serum, secretions, and urine of man after parenteral administration of vaccines. Infect Immun (1970) 0.76
The secretory immune system of the intestine. Gut (1972) 0.75
Gastric form of alpha chain disease. Gut (1986) 0.75
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med (1971) 3.13
Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med (1971) 2.62
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis (1990) 2.18
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Respiratory syncytial virus. Curr Probl Pediatr (1993) 1.93
Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol (1985) 1.92
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J (1990) 1.88
Potential spectrum of etiological agents of viral enteritis in hospitalized infants. J Clin Microbiol (1983) 1.85
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis (2001) 1.78
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr (1992) 1.70
Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol (1977) 1.69
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr (1980) 1.63
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol (1991) 1.60
Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis (1989) 1.55
Rubella-virus infection in juvenile rheumatoid arthritis. Lancet (1975) 1.52
Arthritis associated with induced rubella infection. J Immunol (1971) 1.51
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45
Immunologic aspects of human colostrum and milk. II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation. J Pediatr (1978) 1.44
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis (1983) 1.41
Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine. J Pediatr (1969) 1.40
Enzyme immunoassay with monoclonal antibodies for the detection of rotavirus in stool specimens. J Infect Dis (1985) 1.39
Reinfection of mice with respiratory syncytial virus. J Med Virol (1991) 1.39
Diphtheria outbreaks in immunized populations. N Engl J Med (1988) 1.38
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis (1979) 1.38
Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun (1991) 1.38
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol (1996) 1.35
Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child (1981) 1.34
Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis (1990) 1.34
Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis (1977) 1.33
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med (1977) 1.32
Immunologic aspects of hepatitis-associated antigen and antibody in human body fluids. J Immunol (1973) 1.32
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr (1976) 1.31
Age-dependent rotavirus-enterocyte interactions. Proc Soc Exp Biol Med (1982) 1.31
Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis (1997) 1.31
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol (1998) 1.28
Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol (1982) 1.28
Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol (1987) 1.27
Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol (1990) 1.27
Rapid detection of poliovirus by reverse transcription and polymerase chain amplification: application for differentiation between poliovirus and nonpoliovirus enteroviruses. J Clin Microbiol (1993) 1.26
Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med (1990) 1.26
Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26
Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol (1987) 1.23
Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr (1979) 1.23
Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol (1991) 1.22
Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr (1986) 1.21
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Respiratory syncytial virus infection in anti-mu-treated mice. J Virol (1991) 1.20
Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol (1988) 1.20
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol (1988) 1.20
Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol (1984) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Poliovirus antibody response in patients with acute leukemia. J Pediatr (1971) 1.16
The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med (1980) 1.15
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14
Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation. J Pediatr (1978) 1.13
The role of immunoglulins in the mechanism of mucosal immunity to virus infection. Pediatr Clin North Am (1970) 1.13
The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res (1988) 1.12
Mucosal immune response to poliovirus vaccines in childhood. Rev Infect Dis (1984) 1.12
Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man. J Med Virol (1981) 1.11
Natural history of parainfluenza virus infection in childhood. J Pediatr (1982) 1.11
Otitis media in children: local immune response to nontypeable Haemophilus influenzae. Infect Immun (1989) 1.10
Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand (1976) 1.09
Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J Med Virol (1989) 1.08
Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis (1982) 1.08
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol (1992) 1.06
Terrapene heart (TH-1), a continuous cell line from the heart of the box turtle Terrapene carolina. Exp Cell Res (1967) 1.06
Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. J Pediatr (1979) 1.06
Isolation and characterization of viruses from the kidneys of Rana pipiens with renal adenocarcinoma before and after passage in the red eft (Triturus viridescens). J Virol (1968) 1.06
Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans. J Infect Dis (1978) 1.05
Viral vaccination via the mucosal routes. Rev Infect Dis (1980) 1.05
Growth curve studies of the suckling mouse cataract agent in individual compartments of the eye. Proc Soc Exp Biol Med (1969) 1.04
Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis (1993) 1.03
Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans. Infect Immun (1979) 1.03
Rubella immunization of volunteers via the respiratory tract. Infect Immun (1973) 1.02
Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites. J Gen Virol (1987) 1.02
Enhanced efficiency of echovirus 6 by a transferable factor in cultured human cells. Proc Soc Exp Biol Med (1967) 1.02
Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med (1968) 1.02